Healthy lifestyle as a decisive factor in the prevention of cardiovascular diseases

Sargsian V.D.; Safarian A.S.; Kamyshova T.V.; Nebieridze D.V.

doi:https://doi.org/10.17116/profmed20192206256

Close metadata

Recommended articles:

Risk factors and adverse outcomes of cardiovascular diseases in people with high normal blood pressure of the Ryazan region. (5-year prospective follow-up). Russian Journal of Preventive Medicine. 2025;(2):31-37

Associations of subclinical atherosclerosis with somatic diseases. Russian Journal of Preventive Medicine. 2025;(2):109-113

Prevalence of cerebrovascular diseases risk factors according to the cohort survey data in Bishkek, Kyrgyz Republic. Russian Journal of Preventive Medicine. 2025;(3):34-39

Potential for the use of nutraceuticals for hyperlipidemia correction. Russian Journal of Preventive Medicine. 2025;(3):40-45

Features of primary and recurrent ischemic stroke in men aged 18—50 years. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):65-74

Treatment of children with blunt spleen injury throughout 25-year period in Sevastopol and the Republic of Crimea. Pirogov Russian Journal of Surgery. 2025;(2):67-76

Giant popliteal artery aneurysm. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):115-119

Early complications after surgical treatment of spontaneous pneumothorax: risk factors analysis. Pirogov Russian Journal of Surgery. 2025;(3):24-32

Factors determining postoperative mortality in patients with hypertensive intracerebral hematomas. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):35-43

Increased expression of circular RNA circSPARC and circTMEM181 in coronary atherosclerosis. Molecular Genetics, Microbiology and Virology. 2025;(1):24-29

Abstract:

Global health system changes have occurred over the past decades. The main causes of mortality and disability are now chronic noncommunicable diseases in adults: these are responsible for 75% of all deaths in the Russian Federation. The main place is occupied by cardiovascular diseases (CVD). The proportion of people of over working age is expected to significantly increase in the United States from 2010 to 2030. Together with the rising prevalence of risk factors (RF), this will cause a considerable increase in the incidence of CVD. There may be a decrease in mortality and an increase in life expectancy due to the control of cardiovascular risk factors, such as hypertension, smoking, hypercholesterolemia, diabetes mellitus, abdominal obesity, alcohol intake, and a sedentary lifestyle.

Keywords:

healthy lifestyle

prevention of cardiovascular diseases

risk factors

markers of inflammation

atherosclerosis

Authors:

Sargsian V.D.

FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990

Safarian A.S.

National Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow, Russia, 101990

Kamyshova T.V.

FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990

Nebieridze D.V.

FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990

Close metadata

References:

Ustav (Konstituciya) WHO,. V kn.: Osnovnye dokumenty, Dopolnenie, 2006 g. Zheneva: WHO; 2006. (In Russ.) https:www.who. int/entity/governance/eb/who_constitution_ru.pdf
Health observation patients with noncommunicable diseases and with high risk of their development. Guideline. Under red. Boytsov S.A., Chuchalin A.G. M. 2014. (In Russ.) https://www.gnicpm.ru, http://www.ropniz.ru
Barquera S, Pedroza-Tobias A, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015;46(5):328-338.
Oganov RG, Maslennikova GYa. Demographic tendency in Russian Federation: Impact of cardiovascular diseases. Cardiovascular therapy and prevention. 2012;1:5-10. (In Russ.)
Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933-944.
Odden MC, Coxson PG, Moran A, et al. The impact of the aging population on coronary heartdisease in the United States. Am J Med. 2011;124(9):827-833.
Leifheit-Limson EC, Spertus JA, Reid KJ, et al. Prevalence of traditional cardiac risk factors and secondary prevention among patients hospitalized for acute myocardial infarction (AMI): variation by age, sex, and race. J Womens Health (Larchmt). 2013;22:8:659-666.
Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease overall findings and diffe-rences by age for 316 099 white men. Arch Intern Med. 1992;152-151:56-64.
Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287:8:1003-1010.
Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ. 2000;321: 7272:1322-1325.
Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:6925:367-372.
Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis. 1988;8(6):737-741.
Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170.000 participants in 26 randomised trials. Lancet. 2010;376:1670-1681.
Libby P. Changing concepts of atherogenesis. J Intern Med. 2000;247:349-358.
Ross R. Atherosclerosis — an inflammatory disease. N Engl J Med. 1999;340:115-126.
Straczek C, Ducimetiere P, Barberger-Gateau P, et al. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study. Journal of the American Geriatrics Society. 2003;58:129-135.
Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine. 2008;359:21:2195-2207.
Proctor MJ, McMillan DC, Horgan PG, et al. Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study. PLoS ONE. 2015;10:3:e0116206.
Shlipak MG, Ix JH, Bibbins-Domingo K, et al. Biomarkers to predict recurrent cardiovascular disease: the heart and soul study. Am J Med. 2008; 121:1:50-57.
Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279:1477-1482.
Andresdottir MB, Sigfusson N, Sigvaldason H, Gudnason V. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study. Am J Epidemiol. 2003;158:9:844-851.
Piepoli M, et al. European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2016;37(29):2315-2381.
Chu P, Pandya A, Salomon JA, et al. Comparative effectiveness of personalized lifestyle management strategies for cardiovascular disease risk reduction. J Am Heart Assoc. 2016;4(3):e002737. PMC free article.
Sattelmair J, Pertman J, Ding EL, et al. Dose response between physical activity risk of coronary heart disease: a meta-analysis. Circulation. 2011;124:789-795.
Moore SC, Patel AV, Matthews CE, et al. Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med. 2012;9:e1001335.
Talbot LA, Morrell CH, Fleg JL, Metter EJ. Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging. Prev Med. 2007;45:169-176.
Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta. 2010;411:785-793.
Vieira VJ, Valentine RJ, Wilund KR, et al. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. Am Am J Public Health. 2012;102:698-704.
Fernandez DM, Clemente JC. Giannarelli c physical activity, immune system, and the microbiome in cardiovascular disease front. Physiol. 29 June 2018. https://doi.org/10.3389/fphys.2018.00763
Rana JS, Arsenault BJ, Després JP, et al. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J. 2011;32:336-344. Crossref Medline Google Schola.
Gleeson M, Bishop NC, Stensel DJ, et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11:607-615.Crossref Medline Google Scholar.
Hamer M, Sabia S, Batty GD, et al. Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II. Cohort Study Circulation. 2012;126:928-933. https://doi.org/10.1161/Circulationaha.112.103879
The New 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease Running Title: Bittner; New Guideline for Primary Prevention Vera Bittner, MD, MSPH Division of Cardiovascular Disease, University of Alabama at Birmin.ham, Birmingham, AL. https://doi.org/10.1161/Circulationaha.119.040625
Cardiovascular prevention 2017. National guidelines Developed by the Committee of experts of the Russian Society of Cardiology (RSC), Russian Society of Preventive Cardiology (RSPC), Russian Society of Non-Communicable Diseases Russ J Cardiol. 2018;23(6):7-122. (In Russ.) https://doi.org/10.15829/1560-4071-2018-6-7-122
Critchley J, Capewell S. Smoking cessation for the secondary prevention of cor-onary heart disease. Cochrane Database Syst Rev. 2004;1:CD003041.
Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328:1519.
Kiiskinen U, Vartiainen E, Puska P, Aromaa A. Long-term cost and life-expectancy consequences of hypertension. J Hypertens. 1998;16:1103-1112.
Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTER-HEART study): case-control study. Lancet. 2004;364:937-952.
Spindler H, Pedersen SS. Posttraumatic stress disorder in the wake of heart disease: prevalence, risk factors, and future research directions. Psychosom Med. 2005;67:715-723.
Pogosova N, Saner H, Pedersen SS, et al. Psychosocial aspects in cardiac rehabilitation: from theory to practice. A position paper from the Cardiac Rehabilitation Section of the Euro-pean Association of Cardiovascular Prevention and Rehabilitation of the Euro-pean Society of Cardiology. Eur J Prev Cardiol. 2015;22:1290-1306.
European Heart Network. Diet, physical activity and cardiovascular disease preven-tion in Europe. Brussels, Belguim: European Heart Network; 2011.
Ludwig DS, Peterson KE, Gormakaer SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet. 2001;357:505-508.
Vartanian L, Schwartz M, Brownell K. Effects of soft drink consumption on nutrition and health: a systematic review and meta analysis. American Journal of Public Health. 2007;97:667-675. https://doi.org/10.2105/AJPH.2005.083782
Martinez-Gonzalez MA, Salas-Salvado J, Estruch R, et al. Benefits of the Mediterranean diet: insights from the PREDIMED Study. Prog Cardiovasc Dis. 2015;58(1):50-60. https://doi.org/10.1016/j.pcad.2015.04.003
Ros E, Martinez-Gonzalez MA, Estruch R, et al. Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study. Adv Nutr. 2014;5(3):330-336. https://doi.org/10.3945/an.113.005389
Widmer RJ, Flammer AJ, Lerman LO, et al. The mediterranean diet, its components, and cardiovascular disease. Am J Med. 2015;128(3):229-238. https://doi.org/10.1016/j.amjmed.2014.10.014
Rees K, Hartley L, Flowers N, et al. ‘Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;(8):CD009825.
Geil PB, Anderson JW, Gustafson NJ. Women and men with hypercho-lesterolemia respond similarly to an American Heart Association step 1 diet. J Am Diet Assoc. 1995;95(4):436-441.
Miller M, Beach V, Sorkin JD, et al. Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance. J Am Diet Assoc. 2009;109(4):713-717. PMC free article.
Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001-2007. https://doi.org/10.1001/jama.280.23.2001
Berkow SE, Barnard N. Vegetarian diets and weight status. Nutr Rev. 2006;64(4):175-188. https://doi.org/10.1111/j.1753-4887.2006.tb00200.x
Key TJ, Fraser GE, Thorogood M, et al. Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76.000 men and women in five prospective studies. Public Health Nutr. 1998;1(1):33-41. https://doi.org/10.1079/PHN19980006
Appleby PN, Thorogood M, McPherson K, Mann JI. Associations between plasma lipid concentrations and dietary, lifestyle and physical factors in the Oxford Vegetarian Study. J Hum Nutr Diet. 1995;8(5):305-314. https://doi.org/10.1111/j.1365-277X.1995.tb00324.x
Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? Am J Clin Nutr. 2009;89(5):1607—1612. https://doi.org/10.3945/ajcn.2009.26736K
Ronksley PE, Brien SE, Turner BJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:671.
Holmes MV, Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:4164.